Literature DB >> 33742331

HER2 Molecular Marker Scoring Using Transfer Learning and Decision Level Fusion.

Suman Tewary1,2, Sudipta Mukhopadhyay3.   

Abstract

In prognostic evaluation of breast cancer, immunohistochemical (IHC) marker human epidermal growth factor receptor 2 (HER2) is used for prognostic evaluation. Accurate assessment of HER2-stained tissue sample is essential in therapeutic decision making for the patients. In regular clinical settings, expert pathologists assess the HER2-stained tissue slide under microscope for manual scoring based on prior experience. Manual scoring is time consuming, tedious, and often prone to inter-observer variation among group of pathologists. With the recent advancement in the area of computer vision and deep learning, medical image analysis has got significant attention. A number of deep learning architectures have been proposed for classification of different image groups. These networks are also used for transfer learning to classify other image classes. In the presented study, a number of transfer learning architectures are used for HER2 scoring. Five pre-trained architectures viz. VGG16, VGG19, ResNet50, MobileNetV2, and NASNetMobile with decimating the fully connected layers to get 3-class classification have been used for the comparative assessment of the networks as well as further scoring of stained tissue sample image based on statistical voting using mode operator. HER2 Challenge dataset from Warwick University is used in this study. A total of 2130 image patches were extracted to generate the training dataset from 300 training images corresponding to 30 training cases. The output model is then tested on 800 new test image patches from 100 test images acquired from 10 test cases (different from training cases) to report the outcome results. The transfer learning models have shown significant accuracy with VGG19 showing the best accuracy for the test images. The accuracy is found to be 93%, which increases to 98% on the image-based scoring using statistical voting mechanism. The output shows a capable quantification pipeline in automated HER2 score generation.
© 2021. Society for Imaging Informatics in Medicine.

Entities:  

Keywords:  Deep learning; HER2 molecular marker; Image analysis; Immunohistochemical (IHC) analysis; Transfer learning

Mesh:

Substances:

Year:  2021        PMID: 33742331      PMCID: PMC8329150          DOI: 10.1007/s10278-021-00442-5

Source DB:  PubMed          Journal:  J Digit Imaging        ISSN: 0897-1889            Impact factor:   4.903


  24 in total

1.  Quantitation of HER2/neu expression in primary gastroesophageal adenocarcinomas using conventional light microscopy and quantitative image analysis.

Authors:  Jennifer Jeung; Roshan Patel; Lizette Vila; Dara Wakefield; Chen Liu
Journal:  Arch Pathol Lab Med       Date:  2012-06       Impact factor: 5.534

Review 2.  Deep learning.

Authors:  Yann LeCun; Yoshua Bengio; Geoffrey Hinton
Journal:  Nature       Date:  2015-05-28       Impact factor: 49.962

3.  Epithelium-Stroma Classification via Convolutional Neural Networks and Unsupervised Domain Adaptation in Histopathological Images.

Authors:  Yue Huang; Han Zheng; Chi Liu; Xinghao Ding; Gustavo K Rohde
Journal:  IEEE J Biomed Health Inform       Date:  2017-04-06       Impact factor: 5.772

4.  ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry.

Authors:  Vilppu J Tuominen; Teemu T Tolonen; Jorma Isola
Journal:  Histopathology       Date:  2012-02-01       Impact factor: 5.087

5.  Automated segmentation of cell membranes to evaluate HER2 status in whole slide images using a modified deep learning network.

Authors:  Fariba Damband Khameneh; Salar Razavi; Mustafa Kamasak
Journal:  Comput Biol Med       Date:  2019-05-30       Impact factor: 4.589

Review 6.  The assessment of HER2 status in breast cancer: the past, the present, and the future.

Authors:  Hiroaki Nitta; Brian D Kelly; Craig Allred; Suzan Jewell; Peter Banks; Eslie Dennis; Thomas M Grogan
Journal:  Pathol Int       Date:  2016-04-07       Impact factor: 2.534

7.  Quantitative image analysis of immunohistochemical stains using a CMYK color model.

Authors:  Nhu-An Pham; Andrew Morrison; Joerg Schwock; Sarit Aviel-Ronen; Vladimir Iakovlev; Ming-Sound Tsao; James Ho; David W Hedley
Journal:  Diagn Pathol       Date:  2007-02-27       Impact factor: 2.644

8.  HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissues.

Authors:  Talha Qaiser; Abhik Mukherjee; Chaitanya Reddy Pb; Sai D Munugoti; Vamsi Tallam; Tomi Pitkäaho; Taina Lehtimäki; Thomas Naughton; Matt Berseth; Aníbal Pedraza; Ramakrishnan Mukundan; Matthew Smith; Abhir Bhalerao; Erik Rodner; Marcel Simon; Joachim Denzler; Chao-Hui Huang; Gloria Bueno; David Snead; Ian O Ellis; Mohammad Ilyas; Nasir Rajpoot
Journal:  Histopathology       Date:  2017-10-27       Impact factor: 5.087

9.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; David G Hicks; Mitch Dowsett; Lisa M McShane; Kimberly H Allison; Donald C Allred; John M S Bartlett; Michael Bilous; Patrick Fitzgibbons; Wedad Hanna; Robert B Jenkins; Pamela B Mangu; Soonmyung Paik; Edith A Perez; Michael F Press; Patricia A Spears; Gail H Vance; Giuseppe Viale; Daniel F Hayes
Journal:  Arch Pathol Lab Med       Date:  2013-10-07       Impact factor: 5.534

Review 10.  Computer-Aided Prostate Cancer Diagnosis From Digitized Histopathology: A Review on Texture-Based Systems.

Authors:  Clara Mosquera-Lopez; Sos Agaian; Alejandro Velez-Hoyos; Ian Thompson
Journal:  IEEE Rev Biomed Eng       Date:  2014-07-17
View more
  1 in total

1.  Analysis on factors behind sentinel lymph node metastasis in breast cancer by color ultrasonography, molybdenum target, and pathological detection.

Authors:  Aibibai Yiming; Muhetaer Wubulikasimu; Nuermaimaiti Yusuying
Journal:  World J Surg Oncol       Date:  2022-03-08       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.